{
  "timestamp": "20250104_024910",
  "model": "gpt-4o",
  "interaction_type": "answer_with_CoT",
  "question_id": "427393cb",
  "question_text": "Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert using chain-of-thought reasoning."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n            You are a medical expert determining the final answer.\n\n                ### Instructions:\n                - Use standard medical knowledge as the primary guide.\n                - Consider enhanced information only if it aligns with consensus.\n                - If conflicting or unclear, present the most likely correct answer based on known facts.\n                - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n            ### Question    \n            Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008\n\n            ### Options\n            opa. Succinylcholine\nopb. Tubocurare\nopc. Pyridostigmine\nopd. Halothane\n\n### Reasoning Chains for Validation:\n- CHAIN: \"Succinylcholine\" -> \"depolarizing neuromuscular blocker\" -> \"exacerbates muscle weakness\" -> \"contraindicated in myasthenia gravis\" -> 95%\n- CHAIN: \"Tubocurare\" -> \"non-depolarizing neuromuscular blocker\" -> \"increased muscle weakness\" -> \"contraindicated in myasthenia gravis\" -> 90%\n- CHAIN: \"Pyridostigmine\" -> \"acetylcholinesterase inhibitor\" -> \"improves neuromuscular transmission\" -> \"used in myasthenia gravis\" -> \"not contraindicated\" -> 85%\n- CHAIN: \"Halothane\" -> \"general anesthetic\" -> \"no direct effect on neuromuscular junction\" -> \"not contraindicated in myasthenia gravis\" -> 80%\n\n### Retrieved Validation Paths:\n- (Pyridostigmine)-TREATS->(Hypertension, Pulmonary)-ASSOCIATED_WITH->(IMPACT gene)-INTERACTS_WITH->(Acetylcholinesterase Inhibitors)\n- (Succinylcholine)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Acetylcholinesterase Inhibitors)-INTERACTS_WITH->(Depolarizing Neuromuscular Blocker)\n- (Halothane)-INTERACTS_WITH->(CA2)-PART_OF->(Tissue membrane)-LOCATION_OF->(General Anesthesia)\n- (Halothane)-INTERACTS_WITH->(CA2)-PART_OF->(Myocardium)-LOCATION_OF->(General Anesthesia)\n- (Paresis)-CAUSES->(Myasthenia Gravis)\n- (Depolarizing Neuromuscular Blocker)-CAUSES->(Fluctuation)-CAUSES->(Disease)-CAUSES->(Paresis)\n\n            ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n            "
    }
  ],
  "response": "```json\n{\n  \"final_analysis\": \"In patients with myasthenia gravis, the use of neuromuscular blockers can exacerbate muscle weakness. Succinylcholine is a depolarizing neuromuscular blocker that can lead to prolonged muscle paralysis in these patients due to their altered neuromuscular transmission. This makes succinylcholine contraindicated in myasthenia gravis. Tubocurare, a non-depolarizing neuromuscular blocker, can also increase muscle weakness, but it is not as commonly highlighted as contraindicated as succinylcholine. Pyridostigmine is an acetylcholinesterase inhibitor used to treat myasthenia gravis by improving neuromuscular transmission, so it is not contraindicated. Halothane is a general anesthetic and does not directly affect the neuromuscular junction in a way that would contraindicate its use in myasthenia gravis. Therefore, based on the consensus and the mechanism of action, succinylcholine is the most likely contraindicated drug in myasthenia gravis.\",\n  \"answer\": \"opa\",\n  \"confidence\": 95\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}